Zapping the brain with personalized alpha waves to fight schizophrenia symptoms

NCT ID NCT01941251

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a more targeted form of transcranial magnetic stimulation (TMS) can help people with schizophrenia whose symptoms don't improve with medication. The treatment uses each patient's own brain wave frequency (alpha rhythm) and MRI scans to precisely stimulate the left prefrontal cortex. Fifty patients will receive either real or sham stimulation over three weeks, and their symptoms and thinking abilities will be measured before, shortly after, and three months later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
navigated transcranial magnetic stimulation (TMS)
What this could lead to
If it works, this could offer a new, non-invasive way to reduce both positive and negative symptoms in people with schizophrenia who haven't responded to standard treatments.
What could go wrong
This is a small, early-phase study with only 50 participants, and previous TMS studies have shown mixed results. The effect may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOAFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Niuvanniemi Hospital

    Kuopio, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.